Sonoma Biotherapeutics
Gauri is an Associate Scientist, Process Development at Sonoma Bio. She beganher cell therapy career at Juno Therapeutics, Inc. (a Celgene company). She was a member of the process science and technology team where she worked on developing manufacturing processes for cell therapy products.
Gauri is a skilled process scientist with experience working on both early and late stage cell therapies. She earned her B.A. in biological sciences from Rutgers University, New Brunswick. In her free time, Gauri enjoys spending time with family and friends and trying new foods.
This person is not in the org chart
This person is not in any offices
Sonoma Biotherapeutics
1 followers
Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted Treg cell therapies designed to induce durable immune tolerance to treat and prevent autoimmune and inflammatory diseases. Sonoma Biotherapeutics is based in South San Francisco and Seattle.